375 related articles for article (PubMed ID: 25081626)
1. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
[TBL] [Abstract][Full Text] [Related]
2. Stress Ulcer Prophylaxis in Critically Ill Children: A Multicenter Observational Study.
Duffett M; Chan A; Closs J; McGloin R; McKelvie G; Pong S; Seto W; Slaney H; Vaninetti G; Vanniyasingam T
Pediatr Crit Care Med; 2020 Feb; 21(2):e107-e113. PubMed ID: 31821206
[TBL] [Abstract][Full Text] [Related]
3. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
Hong MT; Monye LC; Seifert CF
Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
[TBL] [Abstract][Full Text] [Related]
4. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
Reynolds PM; MacLaren R
Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
[TBL] [Abstract][Full Text] [Related]
5. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
Krag M; Perner A; Wetterslev J; Møller MH
Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
[TBL] [Abstract][Full Text] [Related]
6. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
[TBL] [Abstract][Full Text] [Related]
7. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
Zhou JF; Wan XY; Huang W; Han LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
[TBL] [Abstract][Full Text] [Related]
8. Stress ulcer prophylaxis in critical illness: a Canadian survey.
Shears M; Alhazzani W; Marshall JC; Muscedere J; Hall R; English SW; Dodek PM; Lauzier F; Kanji S; Duffett M; Barletta J; Alshahrani M; Arabi Y; Deane A; Cook DJ
Can J Anaesth; 2016 Jun; 63(6):718-24. PubMed ID: 26911559
[TBL] [Abstract][Full Text] [Related]
9. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
10. A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit.
Preslaski CR; Mueller SW; Kiser TH; Fish DN; MacLaren R
J Clin Pharm Ther; 2014 Dec; 39(6):658-62. PubMed ID: 25243327
[TBL] [Abstract][Full Text] [Related]
11. Stress Ulcer Prophylaxis.
Barletta JF; Bruno JJ; Buckley MS; Cook DJ
Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
[TBL] [Abstract][Full Text] [Related]
12. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
[TBL] [Abstract][Full Text] [Related]
13. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
14. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
Redfern RE; Brown M; Karhoff KL; Middleton JL
South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
[TBL] [Abstract][Full Text] [Related]
15. Benefit of an electronic medical record-based alarm in the optimization of stress ulcer prophylaxis.
Saad EJ; Bedini M; Becerra AF; Martini GD; Gonzalez JG; Bolomo A; Castellani L; Quiroga S; Morales C; Leathers J; Balderramo D; Albertini RA
Gastroenterol Hepatol; 2018; 41(7):432-439. PubMed ID: 29895412
[TBL] [Abstract][Full Text] [Related]
16. Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study.
Alsultan MS; Mayet AY; Malhani AA; Alshaikh MK
Saudi J Gastroenterol; 2010; 16(4):275-9. PubMed ID: 20871193
[TBL] [Abstract][Full Text] [Related]
17. When should stress ulcer prophylaxis be used in the ICU?
Quenot JP; Thiery N; Barbar S
Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
[TBL] [Abstract][Full Text] [Related]
18. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
19. Overuse of acid-suppressive therapy in hospitalized patients.
Nardino RJ; Vender RJ; Herbert PN
Am J Gastroenterol; 2000 Nov; 95(11):3118-22. PubMed ID: 11095327
[TBL] [Abstract][Full Text] [Related]
20. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?
Hussain S; Stefan M; Visintainer P; Rothberg M
South Med J; 2010 Nov; 103(11):1103-10. PubMed ID: 21042168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
